Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07472582

A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With Men

A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With Men: a Pilot Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to investigate whether receiving chatbot-delivered stage-of-change-tailored online interventions is effective in reducing chemsex among men who have sex with men in Hong Kong. The main question it aims to answer is: Does chatbot-delivered stage-of-changed online interventions reduce chemsex among men who have sex with men Eligible participants will be randomly assigned to either the intervention or the control group. The control group will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks. On top of the interventions received by the control group, participants in the intervention group will have access to a chatbot during the 12-week intervention period. The chatbot will deliver 12 weekly episodes of interventions tailored to once's current stage-of-change related to chemsex. The chatbot will also address questions related to chemsex during the intervention period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALChatbot-delivered online interventions and online videosParticipants will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks. The chatbot will deliver 12 weekly episodes of interventions tailored to once's current stage-of-change related to chemsex. The chatbot will also address questions related to chemsex during the intervention period.
BEHAVIORALOnline videos onlyParticipants will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks.

Timeline

Start date
2026-04-01
Primary completion
2027-03-31
Completion
2027-03-31
First posted
2026-03-16
Last updated
2026-03-16

Source: ClinicalTrials.gov record NCT07472582. Inclusion in this directory is not an endorsement.